Three experts give their views on the state of play in cell and gene manufacturing, and the challenges that lie ahead

Will next gen antibodies knock our socks off? Experts consider the future of antibody-based drug development

Patient-centricity needs to be more than a buzzword. Here’s how Boehringer Ingelheim is weaving it into its culture.

What lies ahead for antibody discovery? We ask experts from RQ Bio.

High growth predictions for regenerative medicine are exciting, but what if current capacity can’t keep pace?

Discussing the challenges associated with flu vaccine development – and the emerging technologies hoping to tackle them.

Carl June discusses his pathway into immunology, and the history and success of CAR-T therapy.

From StomachSim, to taste masking, to micronization; check out our special eBook on Formulation

Researchers use genome mining and bioengineering techniques to develop sustainable saponin-based vaccine adjuvants

Modern data strategies are needed as the landscape for clinical trials changes.